EVR
$278.69
Evercore Inc., together with its subsidiaries, operates as an independent investment banking firm in the Americas, Europe, Middle East, Africa, and Asia-Pacific.
Recent News
3 Investment Bank Stocks to Buy From a Flourishing Industry
Efforts to boost operating efficiency, solid trading performance and momentum in underwriting and advisory businesses will aid Zacks Investment Bank industry players, like Morgan Stanley (MS), Interactive Brokers and Evercore (EVR).
Evercore Hire Signals Deeper Biotech Equity Focus For Investors
Evercore (NYSE:EVR) has hired David Ke as a Senior Managing Director in its equity capital markets group. Ke is an experienced biotechnology investment banker, joining to expand the firm’s biotechnology equity capital markets capabilities. The move is intended to deepen Evercore’s expertise and client service for biotech companies seeking equity financing. For you as an investor watching NYSE:EVR, this hire points to a clearer focus on biotechnology within Evercore’s equity capital markets...
Lennar Earnings Miss Is a Bad Sign for Home Builder Stocks-Even if They’re Rising Today
The company’s 16,863 deliveries, a measure of home closings, missed both guidance and consensus expectations, which called for 17,698.
Affiliated Managers Group, PJT, Moelis, Jefferies, and Evercore Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after investors raised concerns over the stability of the private credit market, following a key announcement from a major bank. JPMorgan Chase announced it would be restricting lending to private credit providers. This decision came after the bank marked down the value of several loans in its portfolio, signaling potential stress in this rapidly growing corner of the finance world. The move sparked broader industry jitters, leading to a rush for
Why Evercore’s Higher Price Target Still Leaves Clearway (CWEN) Rated In-Line
Clearway Energy, Inc. (NYSE:CWEN) is one of the 10 Best Renewable Energy Stocks to Buy Now. As of March 7, 2026, Wall Street’s consensus 12-month price target on the stock stood at $40.14, implying about 6.25% upside from its $37.78 trading price. Analyst targets ranged from $34 to $45, while the stock carried a Moderate […]